HCP, Inc. (NYSE:HCP) Shares Bought by BB&T Securities LLC

BB&T Securities LLC boosted its position in shares of HCP, Inc. (NYSE:HCP) by 12.5% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 35,668 shares of the real estate investment trust’s stock after buying an additional 3,976 shares during the quarter. BB&T Securities LLC’s holdings in HCP were worth $1,267,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in HCP. Amundi Pioneer Asset Management Inc. grew its position in HCP by 17.5% during the first quarter. Amundi Pioneer Asset Management Inc. now owns 555,436 shares of the real estate investment trust’s stock valued at $17,384,000 after buying an additional 82,719 shares during the period. Pensionfund DSM Netherlands lifted its holdings in HCP by 12.7% during the second quarter. Pensionfund DSM Netherlands now owns 106,593 shares of the real estate investment trust’s stock valued at $3,409,000 after purchasing an additional 12,000 shares in the last quarter. Pensionfund Sabic lifted its holdings in HCP by 30.3% during the second quarter. Pensionfund Sabic now owns 43,007 shares of the real estate investment trust’s stock valued at $1,375,000 after purchasing an additional 10,000 shares in the last quarter. Eii Capital Management Inc. lifted its holdings in HCP by 11.9% during the second quarter. Eii Capital Management Inc. now owns 67,719 shares of the real estate investment trust’s stock valued at $2,166,000 after purchasing an additional 7,175 shares in the last quarter. Finally, Montecito Bank & Trust purchased a new position in HCP during the second quarter valued at $1,865,000. Institutional investors own 95.80% of the company’s stock.

NYSE:HCP opened at $34.53 on Friday. The company’s 50-day moving average price is $36.24 and its 200-day moving average price is $33.42. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.01. The company has a market cap of $17.57 billion, a P/E ratio of 18.97, a P/E/G ratio of 6.81 and a beta of 0.22. HCP, Inc. has a twelve month low of $26.58 and a twelve month high of $37.93.

HCP (NYSE:HCP) last posted its quarterly earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.52). The business had revenue of $538.00 million during the quarter, compared to analysts’ expectations of $503.65 million. HCP had a return on equity of 12.78% and a net margin of 43.66%. The business’s quarterly revenue was up 18.0% on a year-over-year basis. During the same period in the prior year, the business posted $0.44 earnings per share. On average, analysts expect that HCP, Inc. will post 1.75 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be paid a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 4.29%. The ex-dividend date is Friday, November 1st. HCP’s dividend payout ratio is currently 81.32%.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Several equities analysts have issued reports on the stock. Barclays increased their price objective on shares of HCP from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. ValuEngine downgraded shares of HCP from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Morgan Stanley increased their price objective on shares of HCP from $32.00 to $35.00 and gave the company an “equal weight” rating in a report on Tuesday, September 17th. JPMorgan Chase & Co. raised shares of HCP from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $35.00 to $38.00 in a report on Tuesday, October 8th. Finally, KeyCorp increased their price objective on shares of HCP from $34.00 to $37.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Two research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $36.78.

In other news, COO Thomas Klaritch sold 35,014 shares of the firm’s stock in a transaction dated Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total value of $1,261,204.28. Following the transaction, the chief operating officer now directly owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 0.13% of the company’s stock.

About HCP

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Story: Options Trading – What is a Straddle?

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Leave a Reply

Your email address will not be published. Required fields are marked *

*